Clearside Biomedical Inc. (NASDAQ: CLSD)
$0.8530
-0.0193 ( -4.16% ) 172.2K
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Market Data
Open
$0.8530
Previous close
$0.8723
Volume
172.2K
Market cap
$66.16M
Day range
$0.8350 - $0.9150
52 week range
$0.8010 - $2.1200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 63 | Dec 12, 2024 |
8-k | 8K-related | 13 | Nov 12, 2024 |
10-q | Quarterly Reports | 71 | Nov 12, 2024 |
4 | Insider transactions | 1 | Nov 04, 2024 |
8-k | 8K-related | 46 | Oct 09, 2024 |
10-q | Quarterly Reports | 72 | Aug 12, 2024 |
8-k | 8K-related | 13 | Aug 12, 2024 |
8-k | 8K-related | 55 | Jul 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
3/a | Insider transactions | 1 | Jun 24, 2024 |